Pharmaceutical Industry in India - Comparison With The U.S.

Comparison With The U.S.

The Indian biotech sector parallels that of the U.S. in many ways. Both are filled with small start-ups while the majority of the market is controlled by a few powerful companies. Both are dependent upon government grants and venture capitalists for funding because neither will be commercially viable for years. Pharmaceutical companies in both countries have recognized the potential effect that biotechnology could have on their pipelines and have responded by either investing in existing start-ups or venturing into the field themselves. In both The India and the U.S., as well as in much of the globe, biotech is seen as a hot field with a lot of growth potential.